Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Breast 1

Conditions

Motor Activity 1Leukemia, Myeloid, Acute 1Fatigue 1Breast Cancer With Chronic Lymphedema 1

Interventions

Cyclophosphamide 739Cisplatin 687Gemcitabine 641Bevacizumab 615Carboplatin 604Paclitaxel 600Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 360Capecitabine 342Filgrastim 333Etoposide 328Dexamethasone 312Irinotecan 309pembrolizumab 279Leucovorin 274Cetuximab 267Cytarabine 242Erlotinib Hydrochloride 231Prednisone 227Nivolumab 227Trastuzumab 225Bortezomib 221Vincristine 220Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Completed × Waiting Lists × Clear all
NCT01706081 2019-08-29

Acupuncture for Chronic Lymphedema

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
82 enrolled 10 charts
Breast

Breast Cancer With Chronic Lymphedema

NCT00764231 2012-02-08

A Study of a Home-based Exercise Intervention for Patients With Acute Myeloid Leukaemia (AML)

Toronto Rehabilitation Institute

Phase 2 Completed
40 enrolled
Other hematologic neoplasm

Fatigue, Motor Activity, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡